Loading clinical trials...
Loading clinical trials...
This is a Phase II/III randomized clinical trial of Radiosensitivity-Assisted Personalized Adaptive Radiotherapy Technology (RAPART) in locally advanced non-small cell lung cancer patients. The main o...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Capital Medical University
NCT06755684 · EGFR, Non-Small Cell Lung Cancer, and more
NCT04648033 · Locally Advanced Non-Small Cell Lung Cancer
NCT06287320 · Locally Advanced Non-small Cell Lung Cancer
NCT04846634 · Resectable Locally Advanced Non-small Cell Lung Cancer
NCT04153734 · Locally Advanced Non-small Cell Lung Cancer
University of Hong Kong Shenzhen Hospital
Shenzhen, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions